Chemed Corporation to Present at the 2025 Bank of America Securities Health Care Conference
Chemed Corporation (NYSE: CHE), a leading publicly traded company with two nationally recognized subsidiaries, today announced its participation in the upcoming Bank of America Securities 2025 Health Care Conference, a prestigious industry event bringing together key players in the health care and related services sectors. Chemed is scheduled to present on Tuesday, May 13, 2025, at 3:40 PM Pacific Daylight Time, at the Encore at the Wynn Las Vegas, a prominent venue for major corporate events and investor engagements.
The company’s presentation at the conference will be webcast live, offering analysts, institutional investors, and the general public an opportunity to gain insights into Chemed’s current performance, business strategy, and growth outlook. Interested parties can access the webcast and the accompanying presentation materials by visiting the Investor Relations section of Chemed’s corporate website at www.chemed.com. A replay of the webcast will be made available within 24 hours following the live event and will remain accessible on the website for a period of 90 days.
Chemed Corporation, which is listed on the New York Stock Exchange under the ticker symbol CHE, is headquartered in Cincinnati, Ohio, and operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. Each subsidiary represents a leader in its respective market segment, reinforcing Chemed’s diversified operational focus and its commitment to excellence in both health care services and essential home and business maintenance.
VITAS Healthcare: Leading the Nation in Hospice Care
VITAS Healthcare, a Chemed subsidiary, stands as the nation’s largest provider of end-of-life hospice care. With decades of experience, VITAS delivers compassionate, patient-centered care to individuals facing life-limiting illnesses. Its clinical staff includes physicians, nurses, social workers, chaplains, home health aides, and volunteers, all dedicated to providing holistic, interdisciplinary care designed to support not only the patient but also their families.
As of early 2025, VITAS operates across multiple U.S. states and serves tens of thousands of patients daily in their homes, nursing facilities, assisted living centers, and inpatient hospice units. The organization continues to expand its footprint through innovative care delivery models, technology-driven patient engagement, and partnerships with hospitals and long-term care providers.
The upcoming presentation at the Bank of America Securities Health Care Conference will provide investors and stakeholders with an updated overview of VITAS’s performance metrics, operational highlights, and strategic initiatives, including workforce development, regulatory compliance, and its ongoing efforts to adapt to an evolving health care landscape shaped by demographic shifts and reimbursement dynamics.
Roto-Rooter: America’s Plumbing and Drain Cleaning Leader
In addition to its health care operations, Chemed also owns Roto-Rooter, the nation’s leading provider of plumbing repair and drain cleaning services. With a presence in both residential and commercial markets, Roto-Rooter delivers vital services that support infrastructure reliability, public health, and quality of life.
Founded in 1935 and acquired by Chemed in 1980, Roto-Rooter has grown to become a trusted household name in the United States and Canada. The company offers a wide range of services including emergency plumbing repairs, water damage cleanup, sewer line inspections, and installation of water heaters and sump pumps. Its technicians are trained to use the latest equipment and diagnostic tools, ensuring rapid, reliable service.
Roto-Rooter’s value proposition lies not only in its technical expertise but also in its brand reputation, extensive franchise network, and strong customer satisfaction ratings. The May 13 presentation will explore how Roto-Rooter has maintained profitability and operational efficiency even amid labor market challenges and inflationary pressures.
Strategic Focus and Corporate Governance
Chemed’s inclusion in the Bank of America Securities Health Care Conference underscores the company’s importance to institutional investors and its reputation for consistent performance and long-term value creation. Over the years, Chemed has delivered steady revenue and earnings growth by leveraging the complementary strengths of its two operating divisions.
The company maintains a disciplined capital allocation strategy, regularly returning value to shareholders through dividends and share repurchases, while also reinvesting in core operations. Chemed has a history of strong free cash flow generation, a conservative balance sheet, and a focused acquisition strategy that prioritizes strategic fit and operational synergies.
From a governance standpoint, Chemed is guided by a seasoned management team and an experienced Board of Directors, committed to transparency, shareholder engagement, and ethical business conduct. Its inclusion in multiple ESG indices and focus on regulatory compliance further reflect its standing as a responsible corporate citizen.
Forward-Looking Statements and Investor Guidance
This announcement contains forward-looking statements within the meaning of the federal securities laws. These statements may include remarks regarding Chemed’s future financial performance, strategic initiatives, market conditions, and business outlook. Such statements are based on management’s current expectations and assumptions, as well as information available at the time of publication.
Investors should be aware that forward-looking statements involve a number of risks and uncertainties. Actual results may differ materially from those projected due to a variety of factors, including but not limited to: changes in regulatory requirements; reimbursement policy adjustments; labor shortages; supply chain disruptions; inflationary trends; shifts in consumer demand; competitive pressures; and general economic conditions.
Chemed cautions investors not to place undue reliance on forward-looking statements and explicitly disclaims any obligation to update or revise these statements based on new information, future events, or otherwise, except as required by law.
Chemed’s upcoming presentation at the Bank of America Securities 2025 Health Care Conference represents a valuable opportunity for the investment community to engage directly with company leadership, gain deeper insights into the dual-engine growth model represented by VITAS Healthcare and Roto-Rooter, and evaluate the company’s long-term prospects within the evolving health care and essential services sectors.
As Chemed continues to deliver on its operational commitments and strategic objectives, it remains well-positioned to navigate industry challenges and capitalize on opportunities for sustainable growth. Investors and analysts interested in attending or viewing the webcast are encouraged to visit www.chemed.com for full access to event details, webcast links, and supporting materials.
